| Model ID | 05-009-02 |
| Model Name | Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) - 30 Days |
| Pubmed ID | 15862409 |
| First Author | Halkin |
| Journal | Journal of the American College of Cardiology |
| Year | 2005 |
| Title | Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score |
| Primary Index Condition | Coronary Artery Disease (CAD) |
| Secondary Index Condition | Acute Coronary Syndrome (ACS) |
| Outcome | Mortality |
| Model Sample Size | 2082 |
| Cohort Sample Size | 2082 |
| Number of Events | 44 |
| Follow-Up Duration | Short (<3 months) |
| AUROC | NR |
| Calibration Reported | 1 |
| Covariates | Baseline LVEF <40%; Renal insufficiency; Killip class 2, 3; Final TIMI flow 0-2; Age >65 years; Anemia; Three vessel disease |
| Mesh Terms | To be updated |
| Number of Validations | 2 |
